Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT00289172 | Assess the Immunogenicity & Safety of 2 Doses of Oral Live Attenuated Human Rota(HRV)Vaccine in Healthy Infants in India | PHASE3 | COMPLETED | 360 | — | — | Feb 10, 2006 | Sep 8, 2006 | May 30, 2017 | 4 | India |
| NCT00134732 | Study of 2 Doses of Oral Live Attenuated Human Rotavirus (HRV) Vaccine for the Prophylaxis of Rotavirus Gastroenteritis | PHASE3 | COMPLETED | 150 | — | — | Jul 1, 2005 | May 1, 2006 | Sep 23, 2016 | 6 | South Korea |
| Name | Type | Description |
|---|---|---|
| Live attenuated human rotavirus vaccine | BIOLOGICAL | - |
"Inclusion criteria: * A male or female between, and including, 8 and 10 weeks of age at the time of the first vaccination. * Written informed consent obtained from the parent or guardian of the subject. * Free of obvious health problems as established by medical history and clinical examination be...